 |
|
|
| |
Real-life effectiveness of VOX/SOF/VEL in hepatitis C
patients previously treated with SOF/VEL or GLE/PIB
|
| |
| |
EASL 2023 June 21-24 Vienna
JC. Ruiz-Cobo1, J. Llaneras1, M. Buti1,2, X. Forns2,3,4,5, I. Conde6, A. Arencibia7, M. Diago8,9, J. García-Samaniego2,10,11, J. Castellote5,12,13, S. Llerena14,15, E. Rodriguez16,17, B. Mateos2,18,19,20, M. Rodríguez21,22, I. Fernández23, JM Rosales
24, JL Calleja2,25,26, RM Morillas2,27,28,29, S. Montoliu30,31, A. Gallego32, R. Andrade2,33,34,35, M. Hernandez-Guerra36, E. Badia37, C. Jimeno38, JM. Gonzalez-Santiago2,39, B. Cuenca40, V. Bernal41,42, | M. Delgado43, J. Turnes 44, S. Lens2,3,4,5
|
| |
|
|
|
|
|
